Erythropoietin and blood doping.


Autoria(s): Robinson N.; Giraud S.; Saudan C.; Baume N.; Avois L.; Mangin P.; Saugy M.
Data(s)

2006

Resumo

OBJECTIVE AND METHOD: To outline the direct and indirect approaches in the fight against blood doping in sports, the different strategies that have been used and are currently being used to fight efficiently against blood doping are presented and discussed. RESULTS AND CONCLUSIONS: The paper outlines the different approaches and diagnostic tools that some federations have to identify and target sports people demonstrating abnormal blood profiles. Originally blood tests were introduced for medical reasons and for limiting misuse of recombinant human erythropoietin (rHuEPO). In this way it became possible to prevent athletes with haematocrit levels well above normal, and potentially dangerous for their health, competing in sport. Today, with nearly a decade of blood testing experience, sports authorities should be familiar with some of the limitations and specially the ability of blood tests performed prior to competitions to fight efficiently against the misuse of rHuEPO, blood transfusion, and artificial haemoglobin.

Identificador

http://serval.unil.ch/?id=serval:BIB_2B1E0A4886DF

isbn:1473-0480[electronic]

pmid:16799100

doi:10.1136/bjsm.2006.027532

isiid:000238533900008

Idioma(s)

en

Fonte

British journal of sports medicine, vol. 40 Suppl 1, pp. i30-4

Palavras-Chave #Blood Transfusion; Doping in Sports; Erythropoietin, Recombinant; Humans; Sports; Substance Abuse Detection
Tipo

info:eu-repo/semantics/review

article